Join the club for FREE to access the whole archive and other member benefits.

Lineage Cell Therapeutics

Lineage is a clinical-stage biotechnology company developing novel cell therapies

Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

Visit website:




Details last updated 31-Dec-2019

People at Lineage Cell Therapeutics

Brian M. Culley

Mr. Culley occupies the position of President, CEO & Independent Director at Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics News

Longevity Technology interviews Lineage's CEO on the role of cell therapy in improving human longevity

Longevity Technology - 03-Aug-2023

Details magic of converting stem cells to any cell type and transplanting them to treat age-related conditions


RPE-Cell therapy might potentially prevent blindness in dry AMD

Biospace - 14-Jun-2021

Lineage CEO says “it offers a whole new paradigm to treat the disease”


Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year


Method of Generating Induced Pluripotent Stem Cells

Longevity Technology - 10-Dec-2019

New reprogramming technology could provide an alternate source of material needed for therapies